Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $169.50 USD
Change Today -3.80 / -2.19%
Volume 2.9M
ALXN On Other Exchanges
As of 8:10 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard Bell M.D.

Co-Founder and Chairman of the Board, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Leonard Bell, also known as Lenny, M.D., Co-Founded Alexion Pharmaceuticals, Inc. in 1992, has been its Chairman of the Board since October 2014 and served as Chief Executive Officer from January 1992 to March 31, 2015. Dr. Bell served as Secretary of Alexion Pharmaceuticals, Inc. since 1992 and as its Treasurer since January 1992. From January 1992 to March 2002, Dr. Bell also served as the President of Alexion Pharmaceuticals, Inc. He has been a Director of Alexion ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Co-Founder and Chairman of the Board
Former Director


Brown University
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,200,000

Stock Options*

Restricted Stock Awards$4,270,038
All Other Compensation$17,654
Exercised Options180,664
Exercised Options Value$21,844,933
Exercisable Options2,073,417
Exercisable Options Value$222,345,755
Unexercisable Options498,045
Unexercisable Options Value$30,768,616
Total Value of Options$274,959,304
Total Number of Options2,752,126

Total Compensation*

Total Annual Cash Compensation$3,617,654
Total Short Term Compensation$1,200,000
Other Long Term Compensation$4,287,692
Total Calculated Compensation$13,388,704
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $169.50 USD -3.80


Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at